Inverness Medical Innovations is a leading provider of innovative diagnostic products. With focus on Women's Health, Blood Borne Pathogens, Oncology, Respiratory and Infectious Diseases and Cardiology, the current product portfolio targets more than 100 disease states and conditions.
As well as leading the way in advanced technologies for professional diagnostic markets we remain committed to advancing healthcare through a continual flow of innovative new products driven by our strategy of investing in R & D and intellectual property. By maintaining our own state-of-the-art manufacturing facilities, we produce high-quality, cutting edge products at the speed of life.
Through our internal R & D programmes, some strategic acquisitions and further planned acquisitions, our portfolio is rapidly growing and evolving. Some of the Inverness Medical Professional brands include Biosite Triage®, Cholestech®, Clearview®, BinaxNOW®, Determine®, and Inverness Medical TestPack® +Plus ensuring that we are at the forefront of the global clinical rapid diagnostics market.
Other products are also available from Inverness Medical Innovations including ACB (Albumin Cobalt Binding) test for Ischemia Modified Albumin.
Inverness Medical has a vision to develop, manufacture and market comprehensive rapid diagnostic test products for assessing critical and chronic conditions, enabling individuals to improve health and quality of life.
Simplicity, speed, reliability and accuracy are all key elements of professional diagnostic products. So it is with these attributes in mind that the Clearview range of products was developed for the healthcare industry. High quality immunoassays have demonstrated efficiency in clinics, hospitals and laboratories around the world.
Within Clearblue’s extensive product range is Clearview HCG pregnancy test, a rapid diagnostic device for the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine. The presence and rapid rise of hCG levels in urine make it an excellent marker for the diagnosis of pregnancy. With proven accuracy of >99% Clearview HCG is a cost effective diagnostic test for healthcare professionals. Clearview also offer an Respiratory Syncytial Virus (RSV) test. RSV is the major cause of serious lower respiratory disease. Early diagnosis of RSV infection allows treatment to, shorten course of illness, reduce severity of symptoms and reduce the spread to others. Clearview RSV is a simple rapid test with results in 15 minutes designed to aid the rapid diagnosis of acute RSV
Accurate and rapid diagnosis of sexually transmitted diseases (STDs) is a major global public health priority, especially in the developing world. Since the emergence of HIV/AIDS, it has become even more critical to diagnose STDs early, not only to save lives but also to prevent the spread of life-threatening infections.
Determine is accurate, easy and innovative technology from Inverness Medical.
Scientifically engineered for dynamic performance anywhere in the world, Determine® allows the detection of the causative organisms of hepatitis B, HIV/AIDS and syphilis to be undertaken simply, accurately and within just 15 minutes.
The simple two step tests require no power, no water, minimal training, just a fingerstick for sample collection and can be easily stored and transported.
Inverness Medical TestPack is designed for use by healthcare professionals for the rapid point-of-care diagnosis of pregnancy and Group A Streptococcus infection. Unlike other rapid tests which only incorporate a procedural control, TestPack has a built in positive and negative control – giving added confidence in the result every time. There is no confusion interpreting the result: a clear '+' or '―'.
For further information please contact the following address:
Inverness Medical Innovations
Unipath Limited
Priory Business Park,
Bedford, MK44 3UP,
United Kingdom
Tel: +44 (0) 1234 835000
Fax: +44 (0) 1234 835001